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A large percentage of patients with HIV/AIDS will develop dermatological complications. Consequently, all practising clinicians
and pathologists in regions with a high prevalence of HIV/AIDS must be familiar with the diverse cutaneous manifestations
of the disease. This paper highlights the fact that biopsy material in this clinical context may occasionally reveal more than
one pathological process. The potential spectrum includes two or more infections in a single skin biopsy (e.g., herpes simplex
and cytomegalovirus infection), neoplastic lesions containing infective organisms (Kaposi sarcoma (KS) and cryptococcosis),
dermatoses in association with neoplastic lesions (e.g., KS and interface dermatitis), or more than one dermatosis in a given
specimen (e.g., papulopruritic eruption and nodular prurigo). Rare biopsies may even demonstrate triple pathology. The
importance of careful examination of skin biopsies in this clinical context is emphasised. Failure to recognise an undiagnosed
concomitant opportunistic infective pathogen could have potentially disastrous consequences for the patient.
1.Introduction
Dermatological disorders are common in patients with
human immunodeﬁciency virus (HIV) infection and the
acquired immunodeﬁciency syndrome (AIDS). It is said that
more than 90% of HIV+ patients will develop cutaneous
complications during the course of their illness, and in a sig-
niﬁcantproportionoftheseindividuals,skinlesionsmaybea
presenting symptom or sign of previously undiagnosed HIV
infection [1, 2]. The spectrum of HIV-related skin disease
includes a wide range of noninfective dermatoses, infective
conditions, adverse drug reactions, and neoplastic prolifer-
ations [1]. It is not uncommon for this group of patients
to manifest with more than one concurrent integumentary
condition. Consequently, any given skin biopsy from an
individual with cutaneous lesions in the presence of under-
lying HIV/AIDS could potentially reveal more than one
pathologicalprocess.Inseverelyimmunosuppressedpatients
who have not received highly active antiretroviral therapy
(HAART), subtle features of a coincidental potentially lethal
opportunistic pathogen (e.g., cryptococcosis) can easily be
overlooked in a specimen predominated by the primary
pathological lesion (e.g., Kaposi sarcoma (KS)) [1, 3, 4].
Although dual or multiple pathological processes are seldom
encountered in single skin biopsies in everyday practise, it
is always wise to maintain a high index of suspicion when
examining specimens from HIV/AIDS patients.
The main objective of this paper is to draw the surgical
pathologist’s attention to the potential spectrum of dual
or multiple pathology, using personally encountered case
examples to illustrate this uncommon phenomenon.
2.Clinicopathological Spectrum
2.1. Overview. Surprisingly little has been written on the
subject, with single case reports comprising most of the rare
examples cited in the literature. Consequently, it is diﬃcult
to ascertain what proportion of skin biopsies from patients
withHIV/AIDSmightharbourdualormultiplepathological
lesions. Based on the author’s experience, it would seem that
a combination of lesions is probably encountered in less
than 2% of cutaneous histological samples obtained from
this group of patients. In a vast majority of documented
cases, the detection of combined pathology has been a2 Pathology Research International
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Figure 1: Papular mucinosis of HIV/AIDS. A mild superﬁcial dermal mononuclear inﬂammatory inﬁltrate is associated with subacute
eczematous changes in the overlying epidermis (a, b), while the deeper dermis shows separation of collagen bundles by interstitial mucin (c).
(a) (b)
Figure 2: Biopsy of a vulval ulcer in a female patient with AIDS. (a) The ulcerated surface epithelium harbours many intranuclear herpes
simplex virus inclusions. (b) Concomitant cytomegalovirus infection of an endothelial cell in the inﬂamed underlying dermis.Pathology Research International 3
Figure 3: Bacillary angiomatosis with incidental cytomegalovirus
(CMV) infection (black arrow). Granular colonies of extracellular
Bartonella bacilli (white arrows) are present amid the background
endothelial cell proliferation and inﬁltrate of polymorphonuclear
leucocytes.
Figure 4: Cutaneous Acanthamoeba infection (black arrow) with
concomitant cytomegalovirus (CMV) infection (red arrow) in
biopsy from a patient with advanced AIDS and widespread
cutaneous ulceration.
reﬂection of marked underlying immunosuppression. Some
more recently reported examples, however, have been a
manifestation of the immune reconstitution inﬂammatory
syndrome (IRIS) [3–5]. Although a detailed account of the
cutaneous manifestations of IRIS is beyond the remit of
this paper, many of the viral, fungal and bacterial infections
alluded to below, and even neoplasms such as KS, may
be a reﬂection of IRIS [3]. Satisfactory clinicopathological
correlation is thus facilitated by knowledge of the patient’s
CD4 T-cell count and an indication of whether or not
HAART has been implemented.
The wide spectrum of potential colesional skin biopsy
pathology is outlined in Table 1. This spectrum encompasses
dual noninfective dermatoses, dual or multiple infections,
Table 1: Overview of the potential spectrum of dual or multiple
pathology in skin biopsies from patients with HIV/AIDS.
Pathology Reference(s)
Dual noninfective dermatoses
PPE & nodular prurigo [1, 6]
Papular mucinosis & eczematous
dermatitis [1, 6–8]
Dual infections
HSV & CMV [9–11]
BA & CMV [12]
Mucormycosis & CMV [13]
Acanthamoebiasis & CMV U
Pneumocystosis & S. aureus
(botryomycosis) [18]
Pneumocystosis & cryptococcosis [19]
MAI & BA [5, 20]
Dual infective and noninfective dermatoses
Histoplasmosis & erythema multiforme U
Folliculitis & interface dermatitis U
Neoplasia in association with infection
KS & cryptococcosis [3, 4, 23–25]
KS & Histoplasma capsulatum infection [28]
KS & Candida infection [29]
KS & MAI infection [33–35]
KS & Tb [3, 37]
KS & CMV [3, 38]
KS & molluscum contagiosum [3, 40]
NHL & MAI infection [35]
(KS & BA∗)[ 30, 32]
Neoplasia in association with noninfective
dermatoses
KS & incidental interface dermatitis [1, 6]
KS & acquired ichthyosis [41]
Dual neoplastic lesions
KS & penile squamous cell carcinoma in situ [41]
Multiple pathology
MAI infection, KS, & cryptococcosis [26]
BA, MAI, & CMV [47, 48]
MAI & CMV & Tb [49]
S. aureus,C M V ,&Mycobacterium spp. [50]
VZV infection, LCV, & KS [1]
PPE: pruritic papular eruption of HIV; HSV: herpes simplex virus;
CMV: cytomegalovirus; BA: bacillary angiomatosis; U: hitherto unreported;
MAI:Mycobacteriumavium-intracellularecomplex;S.aureus:Staphylococcus
aureus;T b :Mycobacterium tuberculosis; KS: Kaposi sarcoma; NHL: non-
Hodgkin lymphoma; VZV: varicella-zoster virus; LCV: leucocytoclastic
vasculitis.
∗Recordedconcurrentlyinthesamepatient,butnotinthesamehistological
specimen.4 Pathology Research International
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Figure 5: Skin biopsy from a patient with AIDS-associated histoplasmosis and concomitant erythema multiforme. A lichenoid reaction is
visible in relation to the dermoepidermal interface (a), while the dermis contains conspicuous numbers of Histoplasma capsulatum yeasts
(b), whose presence is highlighted with the aid of a Grocott stain (c).
neoplasia (KS) in association with infection, neoplasia (KS)
with an associated dermatosis, mixed infective and inﬂam-
matory dermatoses, dual neoplastic conditions, and multiple
pathologies. Although this latter group is uncommon, a high
index of suspicion should always be maintained [1]. In most
cases, the detection of more than one pathological lesion
in a single biopsy is fortuitous and unexpected. On other
occasions, however, a detailed history might reveal that the
patient has clinical evidence of more than one type of skin
lesion.Somedermatologistsmaythereforeelecttointention-
ally sample overlapping lesions in a single biopsy [1].
2.2. Dual Noninfective Dermatoses. Since HIV/AIDS may be
associated with a diverse array of noninfective dermatolog-
ical disorders, and patients may often have more than one
skin disease at presentation, it is somewhat surprising that
skin biopsy specimens seldom reveal dual pathology of a
noninfective nature. Two conditions, however, are known to
sometimes demonstrate dual pathology. The ﬁrst of these is
pruritic papular eruption of HIV (papulopruritic eruption),
wherethelongstandingpruritisandexcoriationmaybecom-
plicated by superimposed changes of nodular prurigo [6].
The second condition is papular mucinosis of HIV/AIDS,
where intradermal mucin deposition is accompanied by
concomitantepidermalchangesofaneczematousdermatitis,
as illustrated in Figure 1 [6–8].
2.3. Dual Infections. The increased susceptibility to infection
by a wide range of opportunistic pathogens is a hallmark of
HIV/AIDS. It is, therefore, essential that histological speci-
mens in this clinical context are always examined carefully
to ensure that a second (or perhaps even a third) infective
organismisnotoverlooked[1].Themostfrequentlyencoun-
tered copathogen is cytomegalovirus (CMV). CMV is often
identiﬁed in the dermis in biopsies obtained from genital
or perineal ulcers caused by herpes simplex virus (Figure 2),
and associated vasculitis is not uncommon [1, 9–11].
CMV infection has also been documented in association
with bacillary angiomatosis (BA) (Figure 3)a n dm u c o r m y -
cosis [12, 13]. The author has also encountered a case
of widespread cutaneous ulceration due to vasculitis in
the presence of acanthamoebiasis and concomitant CMV
infection (Figure 4). Although skin lesions due to infection
with Acanthamoeba spp. may occur in patients with AIDS,
to date there have been no additional examples with CMV
coinfection recorded in the literature [14–17].Pathology Research International 5
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Figure 6: (a) Suppurative folliculitis (black arrow) associated with interface dermatitis (red arrow), the latter ascribed to recently introduced
HAART. There is a ﬂorid folliculocentric neutrophilic inﬁltrate (b), with the lumen of the partially disrupted follicle containing both
Staphylococcus organisms and Malassezia yeasts (c). Drug-induced pauci-inﬂammatory interface dermatitis is observed in the neighbouring
epidermis (d, e). (By courtesy of Dr. J. Rigby, National Health Laboratory Service and the University of the Witwatersrand, Johannesburg,
South Africa.)
Cutaneous infection with Pneumocystis jiroveci (formerly
P. carinii) is a rare complication of HIV/AIDS. There
have, however, been single case reports of coinfection with
other organisms, namely, botryomycosis due to concomitant
Staphylococcus aureus infection, and skin lesions harboring
both Pneumocystis organisms and Cryptococcus neoformans
yeasts [18, 19]. BA has been reported in association with
Mycobacterium avium-intracellulare (MAI) infection [5, 20].
Cases with lesions containing three separate infective organ-
isms are discussed in Section 2.8.6 Pathology Research International
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Figure 7: (a) AIDS-associated Kaposi sarcoma with concomitant cutaneous cryptococcosis. Cryptococcus neoformans yeasts (including
capsule deﬁcient forms) are present amid the background spindle cell proliferation (b), with the mucicarmine preparation (c) highlighting
the mucoid capsule around individual yeasts; narrow-based budding is present (inset). The KS lesional cells demonstrate immunoreactivity
for both CD31 (d) and human herpes virus type 8 (HHV-8) (e).
2.4. Dual Infective and Noninfective Dermatoses. This phe-
nomenon has, to the best of one’s knowledge, not been
addressed in the literature. Vacuolar interface dermatitis
is a reaction pattern with a number of potential causes
in patients with HIV/AIDS. Causes are diverse, including
the acute exanthem of HIV infection, a morbilliform drug
rash, erythema multiforme, and so-called AIDS interface
dermatitis [1]. Doubt has been expressed regarding the
validity of the latter as a distinct clinicopathological entity,
as a signiﬁcant proportion of patients whose biopsies
revealed interface dermatitis had one or more opportunistic
infections and/or had been receiving one or more drugs atPathology Research International 7
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Figure 8: (a) Facial Kaposi sarcoma (KS) in an adult man undergoing treatment for pulmonary tuberculosis. A noncaseating granuloma is
present within the KS lesion in the lower half of the ﬁeld (arrow). (b) Detail of the vasoformative KS proliferation. (c) Higher magniﬁcation
of the tuberculous granuloma. Although acid-fast bacilli could not be demonstrated on Ziehl-Neelsen staining, mycobacterial DNA was
detected by PCR. (d) CD31 immunostain highlighting the background KS. (e) The KS lesional cells were also immunoreactive for HHV-8.
the time of diagnosis [1, 6, 21, 22]. There are nevertheless
occasions in which interface dermatitis is detected coinci-
dentally in a biopsy performed for another reason (e.g.,
conﬁrmation of KS) and in which there is no signiﬁcant
drug history (see below) [1, 6]. The author has encountered
cases where careful clinical correlation has elucidated the
cause of this reaction pattern when a skin biopsy has been
performed for conﬁrmation of another condition. Anecdotal
examples include histoplasmosis with erythema multiforme
(Figure 5),andfolliculitisinassociationwithanadversedrug
reaction to HAART (Figure 6).
2.5. Neoplasia in Association with Infection. KS skin lesions
may rarely contain coincidental infective organisms. Failure8 Pathology Research International
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Figure 9: Skin biopsy from a patient with HIV-associated acquired ichthyosis and Kaposi sarcoma. The epidermis displays prominent
hyperkeratosis (a, b), while the underlying dermis is expanded by a typical plaque-stage Kaposi sarcoma proliferation (c).
to recognise the opportunistic pathogen, whose presence is
often masked by the more obvious background spindle cell
proliferation, could have grave prognostic implications. To
date there have been only nine recorded cases of AIDS-
associated KS with colesional cryptococcosis, one of whom
had oral lesions exclusively [4, 23–27]. The author has
encountered three additional examples of KS with incidental
Cryptococcus neoformans infection, including the case illus-
trated in Figure 7.
Histoplasma capsulatum coexistent with KS in a single
lesion has also been reported [28]. In this context, H.
capsulatum yeasts should be distinguished from infection
with capsule deﬁcient forms of C. neoformans occurring in
association with KS [3, 4]. There are two documented cases
of KS with apparent intralesional Candida organisms. The
latter were identiﬁed on ultrastructural examination [29].
Although there are rare reports of patients with concurrent
KS and BA, these cases seem to have presented with separate
lesions, showing no apparent microscopic evidence of BA in
the KS histological specimens and vice versa [30–32].
MAI infection has uncommonly been documented in
association with KS, including one patient who had a facial
non-Hodgkin lymphoma of immunoblastic type containing
acid-fast organisms, and another who had concomitant
colesional cryptococcosis [26, 33–35]. More recently, M.
tuberculosis has also been detected in KS cutaneous lesional
tissue (Figure 8), where its presence may serve as a clue to
underlyingHIVinfection,systemictuberculosis,noncompli-
ance to antituberculous medication, or multidrug resistant
tuberculosis [36]. Although these tuberculoid granulomas
are recognised with relative ease in involved KS lesions,
mycobacterial spindle cell tumours concomitant with KS
may pose a particular diagnostic challenge [3]. This latter
phenomenon has been described in the lymph nodes of
HIV+ patients but has not, to the best of one’s knowledge,
been documented in the skin [37].
Not unexpectedly, KS may occasionally harbour CMV
inclusions, including KS involving the oral cavity [3, 38, 39].
Although the clinical signiﬁcance thereof is the subject of
debate, the identiﬁcation of CMV inclusions in KS may serve
as a sentinel for more serious systemic CMV disease such as
retinitis or pneumonitis [3, 38]. The fortuitous detection of
molluscum contagiosum in KS has also been reported; the
presence of both lesions in a single histological specimen
may be the ﬁrst clue to underlying HIV infection/AIDS
[3, 40].Pathology Research International 9
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Figure 10: (a) Penile squamous cell carcinoma in situ in association with genital Kaposi sarcoma. (b) Detail of the Kaposi sarcoma
proliferation replacing the subepithelial stroma. (c) Severe dysplasia involving the full thickness of the overlying surface epithelium.
2.6. Neoplasia in Association with Noninfective Dermatoses.
Since patients with HIV/AIDS often present with cuta-
neous lesions caused by more than one disease, it is not
entirely unexpected that biopsies performed for histological
conﬁrmation of KS may sometimes show evidence of a
concomitantnoninfectivedermatosis.Althoughuncommon,
it has been the author’s experience that incidental interface
dermatitis is encountered occasionally in the epidermis
overlying a KS lesion [6, 41] .W h i l es o m ee x a m p l e sa r e
almost certainly attributable to a concurrent adverse drug
reaction, some cases have no signiﬁcant pharmacological
history and could perhaps represent examples of so-called
“AIDS interface dermatitis” [1, 6, 21, 22].
There is a well-documented association between AIDS
and acquired ichthyosis, including patients who have pre-
sented with concomitant KS [42–44]. Biopsies from such
patients may therefore reveal histological features of both
conditions,asdepictedinFigure 9[41].Thelatterbiopsywas
intentionally obtained from an area of ichthyosis overlying a
suspected dermal KS lesion on the lower extremity.
2.7. Dual Neoplastic Lesions. AIDS carries an increased risk
of oral and anogenital neoplasia [6, 45, 46]. Rarely, biopsies
of KS genital lesions may reveal coincidental squamous cell
carcinoma in situ,a si l l u s t r a t e di nFigure 10 [41].
2.8. Multiple Pathology. Although rare, single histological
specimens may occasionally reveal more than two patholog-
ical lesions. This rare phenomenon has been documented
in single case reports. Most comprise either three separate
infections,ortwoinfectionsinassociationwithKS.Recorded
examples include the following:
(i) BA, MAI, and CMV coinfection [47, 48],
(ii) Concurrent CMV, MAI, and M. tuberculosis infection
[49],
(iii) Infection with S. aureus,C M V ,a n dMycobacterium
spp. [50],
(iv) MAI, KS, & Cryptococcus infection [26], and
(v) varicella-zoster virus (VZV) infection, leucocytoclas-
tic vasculitis, and KS (Figure 11)[ 1].
The patient whose biopsy is depicted in Figure 11 had
purple-red KS lesions and an associated vesicular eruption.
The sample was intentionally obtained from a somewhat
haemorrhagic lesion on the trunk, where a vesicle was
observed on the surface of a clinical KS lesion.
3. Conclusion
Colesional pathology may easily be overlooked in skin
biopsies from patients with HIV/AIDS, especially when10 Pathology Research International
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Figure 11: Skin biopsy demonstrating multiple HIV/AIDS-related pathology, including a superﬁcial vesicle due to varicella-zoster virus
infection (a), leucocytoclastic vasculitis in the mid- to upper dermis (b), and incidental Kaposi sarcoma in the deeper dermis (c), the latter
conﬁrmed by immunohistochemical staining for HHV-8 (inset). (Reproduced from [1] with permission from BMJ Publishing Group Ltd.).Pathology Research International 11
the primary pathological lesion dominates the histological
picture. It is wise for the surgical pathologist to always
consider dual or multiple pathology when examining biopsy
material from this group of patients. Rigorous adherence to
this principle when studying the routine haematoxylin and
eosin (H&E) stained sections will usually facilitate diagnosis
or at least raise suspicion for a second or perhaps even a
third pathological process. Since it is neither practical nor
cost-eﬀective to perform a panel of histochemical and/or
immunohistochemical stains for potential identiﬁcation of
infectious organisms on each and every biopsy, relevant
stains should be reserved for conﬁrmation of one’s suspicion
based on the H&E ﬁndings. If necessary, additional biopsies
should be recommended for appropriate microbiological
studies, such as fungal culture. A clinical history of polymor-
phous skin lesions should alert the pathologist to the poten-
tial for dual or multiple pathology in a given skin biopsy.
CMV remains the most frequently encountered coin-
cidental pathogen, and whilst its precise pathological sig-
niﬁcance is often uncertain, one should remain cognisant
that the presence of CMV inclusions in a skin biopsy may
serve as a sentinel for more serious systemic involvement [3].
The detection of tuberculous granulomas or Cryptococcus
organismsin KShassimilar implications [3,4,36]. Although
the patients whose biopsies are illustrated herein were largely
HAART-na¨ ıve, awareness that colesional pathology may
be a rare manifestation of IRIS is appropriate in the era
of HAART. A potentially interesting collaborative research
opportunity may reside in a detailed clinicopathological
analysis of a series of such cases.
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